All In Biotech

Drug Trial Radar · NCT03695185

A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy

A Multicenter, Single Arm, Open-label Study to Investigate the Efficacy and Safety of Ravagalimab (ABBV-323) in Subjects With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy

Last checked: Nov 19, 2026Latest source record: Mar 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

42

Actual

Start

Mar 26, 2019

Primary completion

Apr 5, 2021

Study completion Jan 10, 2022

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Oct 4, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study M15-722 is a Phase 2a study to investigate the efficacy and safety of Ravagalimab (ABBV-323) in participants with moderate to severe UC who failed prior therapy.

Conditions

  • Ulcerative Colitis (UC)

Interventions

  • Ravagalimab 600 mgDrug

    Ravagalimab 600 mg was administered intravenously (IV).

  • Ravagalimab 300 mgDrug

    Ravagalimab 300 mg was administered subcutaneously (SC).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Endoscopic Improvement During Induction PeriodTime frame: At Week 8

Locations

34 sites in 10 countries. Site status is shown where the registry gives one.

  • Banner University Medical Cent /ID# 208392

    Tucson, Arizona

  • Meridian Investigator Network /ID# 204646

    Huntington Beach, California

  • Meridian Investigator Network /ID# 218568

    Lakewood, California

  • TLC Clinical Research Inc /ID# 206626

    Los Angeles, California

  • Orange County Institute of Gastroenterology and Endoscopy /ID# 207405

    Mission Viejo, California

  • UC Davis Medical Center /ID# 209402

    Sacramento, California

  • The University of Chicago DCAM /ID# 207086

    Chicago, Illinois

  • Affinity Clinical Research /ID# 206211

    Oak Brook, Illinois

  • Univ New Mexico /ID# 208817

    Albuquerque, New Mexico

  • Penn Presbyterian Medical Center /ID# 206826

    Philadelphia, Pennsylvania

  • Vanderbilt University Medical Center /ID# 204670

    Nashville, Tennessee

  • Clinical Associates in Research Therapeutics of America, LLC /ID# 204689

    San Antonio, Texas

  • Mount Sinai Hospital /ID# 206180

    Toronto, Ontario, Canada

  • Chu de Nice-Hopital L'Archet Ii /Id# 208131

    Nice, Alpes-Maritimes, France

  • Hopital Beaujon /ID# 208129

    Clichy, Île-de-France Region, France

  • CHRU Nancy - Hôpitaux de Brabois /ID# 208133

    Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France

  • Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 207570

    Berlin, Germany

  • Universitaetsklinikum Frankfurt /ID# 207569

    Frankfurt am Main, Hesse, Germany

  • Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 207571

    Kiel, Schleswig-Holstein, Germany

  • Debreceni Egyetem Klinikai Kozpont /ID# 221952

    Debrecen, Hungary

  • Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 221576

    Szeged, Csongrád megye, Hungary

  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 208504

    Milan, Italy

  • University of Catanzaro /ID# 204546

    Catanzaro, Calabria, Italy

  • Presidio Columbus-Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Un /ID# 204549

    Rome, Roma, Italy

  • Maastricht Universitair Medisch Centrum /ID# 204428

    Maastricht, Netherlands

  • Franciscus Gasthuis & Vlietland /ID# 206976

    Rotterdam, Netherlands

  • Elisabeth Tweesteden Ziekenhuis /ID# 206272

    Tilburg, Netherlands

  • Kyungpook National University Hospital /ID# 209912

    Daegu, South Korea

  • Yeungnam University Medical Center /ID# 210447

    Daegu, South Korea

  • Hospital Santa Creu i Sant Pau /ID# 213259

    Barcelona, Spain

  • Hospital General Universitario Gregorio Maranon /ID# 204504

    Madrid, Spain

  • Hospital Universitario La Paz /ID# 210065

    Madrid, Spain

  • Belfast Health and Social Care Trust /ID# 206744

    Belfast, United Kingdom

  • NHS Greater Glasgow and Clyde /ID# 206574

    Glasgow, Scotland, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.